168 related articles for article (PubMed ID: 15927308)
21. Adrenomedullin and diabetes mellitus.
Ruzicska E; Toth M; Tulassay Z; Somogyi A
Diabetes Metab Res Rev; 2001; 17(5):321-9. PubMed ID: 11747138
[TBL] [Abstract][Full Text] [Related]
22. Cyclostome and chondrichthyan adrenomedullins reveal ancestral features of the adrenomedullin family.
Wong MK; Takei Y
Comp Biochem Physiol B Biochem Mol Biol; 2009 Nov; 154(3):317-25. PubMed ID: 19616113
[TBL] [Abstract][Full Text] [Related]
23. Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms.
Nikitenko LL; Blucher N; Fox SB; Bicknell R; Smith DM; Rees MC
J Cell Sci; 2006 Mar; 119(Pt 5):910-22. PubMed ID: 16495482
[TBL] [Abstract][Full Text] [Related]
24. Adrenomedullin and cancer.
Zudaire E; Martínez A; Cuttitta F
Regul Pept; 2003 Apr; 112(1-3):175-83. PubMed ID: 12667640
[TBL] [Abstract][Full Text] [Related]
25. [Adrenomedullin].
Zeng Z
Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):635-7. PubMed ID: 8697932
[No Abstract] [Full Text] [Related]
26. Differentiation of the HaCaT keratinocyte cell line: modulation by adrenomedullin.
Pleguezuelos O; Kapas S
Br J Dermatol; 2006 Apr; 154(4):602-8. PubMed ID: 16536800
[TBL] [Abstract][Full Text] [Related]
27. Small-molecule negative modulators of adrenomedullin: design, synthesis, and 3D-QSAR study.
Roldós V; Martín-Santamaría S; Julián M; Martínez A; Choulier L; Altschuh D; de Pascual-Teresa B; Ramos A
ChemMedChem; 2008 Sep; 3(9):1345-55. PubMed ID: 18759242
[TBL] [Abstract][Full Text] [Related]
28. Identification of vasoactive nonpeptidic positive and negative modulators of adrenomedullin using a neutralizing antibody-based screening strategy.
Martínez A; Julián M; Bregonzio C; Notari L; Moody TW; Cuttitta F
Endocrinology; 2004 Aug; 145(8):3858-65. PubMed ID: 15107357
[TBL] [Abstract][Full Text] [Related]
29. [Adrenomedullin in cardiovascular pathology].
Piroli E; Annoscia C; Ranieri F; Priori F; Rossi F; Santiemma V
Recenti Prog Med; 2004 Mar; 95(3):161-8. PubMed ID: 15143954
[TBL] [Abstract][Full Text] [Related]
30. Adrenomedullin gene expression and peptide levels in the heart and blood vessels of streptozotocin-diabetic rats.
Tang F; Hwang IS; Wong MP; Li YY
Horm Metab Res; 2007 Jan; 39(1):3-8. PubMed ID: 17226106
[TBL] [Abstract][Full Text] [Related]
31. Enhanced vascular responses to adrenomedullin in mice overexpressing receptor-activity-modifying protein 2.
Tam CW; Husmann K; Clark NC; Clark JE; Lazar Z; Ittner LM; Götz J; Douglas G; Grant AD; Sugden D; Poston L; Poston R; McFadzean I; Marber MS; Fischer JA; Born W; Brain SD
Circ Res; 2006 Feb; 98(2):262-70. PubMed ID: 16373602
[TBL] [Abstract][Full Text] [Related]
32. Adrenomedullin: molecular mechanisms and its role in cardiac disease.
Yanagawa B; Nagaya N
Amino Acids; 2007 Jan; 32(1):157-64. PubMed ID: 16583314
[TBL] [Abstract][Full Text] [Related]
33. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
34. [New antihypertensive agents: adrenomedullin].
Kitamura K
Nihon Naika Gakkai Zasshi; 1995 Jan; 84(1):36-40. PubMed ID: 7722365
[No Abstract] [Full Text] [Related]
35. Adrenomedullin. Implications for hypertension research.
Kitamura K; Kangawa K; Matsuo H; Eto T
Drugs; 1995 Apr; 49(4):485-95. PubMed ID: 7789284
[No Abstract] [Full Text] [Related]
36. Adrenomedullin and adrenomedullin binding protein-1 prevent acute lung injury after gut ischemia-reperfusion.
Dwivedi AJ; Wu R; Nguyen E; Higuchi S; Wang H; Krishnasastry K; Marini CP; Ravikumar TS; Wang P
J Am Coll Surg; 2007 Aug; 205(2):284-93. PubMed ID: 17660075
[TBL] [Abstract][Full Text] [Related]
37. Cell and molecular biology of the multifunctional peptide, adrenomedullin.
López J; Martínez A
Int Rev Cytol; 2002; 221():1-92. PubMed ID: 12455746
[TBL] [Abstract][Full Text] [Related]
38. Central and peripheral cardiovascular actions of adrenomedullin 5, a novel member of the calcitonin gene-related peptide family, in mammals.
Takei Y; Hashimoto H; Inoue K; Osaki T; Yoshizawa-Kumagaye K; Tsunemi M; Watanabe TX; Ogoshi M; Minamino N; Ueta Y
J Endocrinol; 2008 May; 197(2):391-400. PubMed ID: 18434369
[TBL] [Abstract][Full Text] [Related]
39. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic peptides for cancer therapy. Part II - cell cycle inhibitory peptides and apoptosis-inducing peptides.
Raucher D; Moktan S; Massodi I; Bidwell GL
Expert Opin Drug Deliv; 2009 Oct; 6(10):1049-64. PubMed ID: 19743895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
